Skip to main content
GoodMoatv1.1
Sign in
CI logo

CI

CompareEarnings: May 31, 2026

Cigna Group (The)

Exchange: NYSESector: HealthcareIndustry: Healthcare Plans

Cigna Corporation (Cigna) is a holding company. Cigna is a global health service company, with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. In the United States, these products and services are offered through employers and other groups, and in selected international markets, Cigna offers supplemental health, life and accident insurance products and international health care coverage and services to businesses, governmental and non-governmental organizations and individuals. Cigna operates in five segments: Health Care, Disability and Life, International, Run-off Reinsurance, and Other Operations, including Corporate-owned Life Insurance. September 2013, Cigna Corporation completed its acquisition of Alegis Care, a portfolio company of Triton Pacific Capital Partners. Effective September 3, 2013, Cigna Corp acquired Home Physicians Management LLC.

Did you know?

Generated $6.9 in free cash flow for every $1 of capital expenditure in FY25.

Current Price

$270.02

+1.01%

GoodMoat Value

$3721.77

1278.3% undervalued
Profile
Valuation (TTM)
Market Cap$72.13B
P/E12.11
EV$92.58B
P/B1.73
Shares Out267.13M
P/Sales0.26
Revenue$274.90B
EV/EBITDA8.15

Cigna Group (The) (CI) Financial Statements

GoodMoat Analysis

Based on data as of March 26, 2026

Cigna demonstrates strong free cash flow generation and a healthy balance sheet, with a robust 11.6% FCF yield and manageable debt. However, its very low operating and profit margins, at 3.3% and 2.2% respectively, are a significant quality concern for a value investor focused on high-return businesses.

Read full analysis
Cigna's financial quality presents a mixed picture for a value investor. The company generates very strong free cash flow, with an 11.6% FCF yield, which comfortably exceeds the framework's favourable threshold of >10-15%. The balance sheet is healthy, with a Debt/Equity ratio of 0.75, indicating manageable leverage that is below the framework's cautionary level of 1.0x Debt/EBITDA. Revenue growth of 10.4% YoY is consistent and respectable. However, several key quality indicators are weak. The operating margin of 3.3% and profit margin of 2.2% are extremely low, failing to meet any typical threshold for a high-quality business and indicating a highly competitive, cost-sensitive model. While the 14.3% ROE is solid, it is below the framework's high-quality benchmark of >15-20%. The growth assessment shows durable top-line expansion but lacks the high, accelerating trajectory (>20%) or clear moat-driven drivers often sought. For a value investor, the standout strength is the powerful cash generation and financial stability, but the razor-thin margins are a persistent headwind to quality and returns on capital. Analysis based on data as of 2024-05-15.

CI Financial Data

EBITDA$11.63B
Revenue (TTM)$274.90B
Gross Profit (TTM)$25.56B
Gross Margin—
Operating Margin3.35%
ROE14.28%
ROA3.77%
Debt/Equity0.75
Current Ratio0.85
FCF$8.39B
FCF Yield11.63%
Piotroski F-Score—
Rev/Share (TTM)$1029.10
50-Day MA$275.29
200-Day MA$283.08
Shares Outstanding0.27B

CI Computed Insights

FCF$8.39B
FCF Growth Rate-0.09%
EPS Growth (CAGR)-0.09%
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

CI Financial Statements & Data

Cigna Group (The) (CI) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Cigna Group (The)'s financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $274.90B. Gross profit (TTM) is $25.56B. EBITDA is $11.63B. Earnings per share (EPS) is $22.18. The P/E ratio is 12.11. Market capitalization is $72.13B.

Free cash flow (FCF) is $8.39B. FCF growth rate is -0.09%. EPS growth CAGR is -0.09%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Cigna Group (The)'s financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.